List of Excipients in API diclofenac potassium tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing diclofenac potassium tablets
Detailed excipient profiles for diclofenac potassium tablets
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diclofenac potassium tablets drug variants containing CELLULOSE, MICROCRYSTALLINE
diclofenac potassium tablets drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
diclofenac potassium tablets drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | diclofenac potassium tablets | 50090-6768 |
| Bryant Ranch Prepack | diclofenac potassium tablets | 71335-9720 |
| >Company | >Ingredient | >NDC |
diclofenac potassium tablets drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| UMEDICA LABORATORIES PRIVATE LIMITED | diclofenac potassium tablets | 60290-057 |
| NuCare PharmaceuticalsInc | diclofenac potassium tablets | 68071-3451 |
| Zydus Pharmaceuticals (USA) Inc | diclofenac potassium tablets | 70710-1832 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
diclofenac potassium tablets drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| UMEDICA LABORATORIES PRIVATE LIMITED | diclofenac potassium tablets | 60290-057 |
| NuCare PharmaceuticalsInc | diclofenac potassium tablets | 68071-3451 |
| Zydus Pharmaceuticals (USA) Inc | diclofenac potassium tablets | 70710-1832 |
| >Company | >Ingredient | >NDC |
diclofenac potassium tablets drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | diclofenac potassium tablets | 50090-6768 |
| Bryant Ranch Prepack | diclofenac potassium tablets | 71335-9720 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
diclofenac potassium tablets drug variants containing LACTOSE MONOHYDRATE
diclofenac potassium tablets drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diclofenac potassium tablets drug variants containing MAGNESIUM STEARATE
diclofenac potassium tablets drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
diclofenac potassium tablets drug variants containing SILICON DIOXIDE
diclofenac potassium tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
diclofenac potassium tablets drug variants containing SODIUM LAURYL SULFATE
diclofenac potassium tablets drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diclofenac potassium tablets drug variants containing TALC
diclofenac potassium tablets drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diclofenac potassium tablets drug variants containing TITANIUM DIOXIDE
diclofenac potassium tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
